Literature DB >> 28882715

Motor Cortex Stimulation in Patients Suffering from Chronic Neuropathic Pain: Summary of Expert Meeting and Premeeting Questionnaire, Combined with Literature Review.

Erkan Kurt1, Dylan J H A Henssen2, Monique Steegers3, Michiel Staal4, Ulrich Beese5, Joseph Maarrawi6, Benoit Pirotte7, Luis Garcia-Larrea8, Dirk Rasche9, Jan Vesper10, Jan Holsheimer11, Wim Duyvendak12, Patrick Herregodts13, Robert van Dongen3, Maarten Moens14.   

Abstract

BACKGROUND: Motor cortex stimulation (MCS) was introduced in the early 1990s by Tsubokawa and his group for patients diagnosed with drug-resistant, central neuropathic pain. Inconsistencies concerning the details of this therapy and its outcomes and poor methodology of most clinical essays divide the neuromodulation society worldwide into "believers" and "nonbelievers." A European expert meeting was organized in Brussels, Belgium by the Benelux Neuromodulation Society in order to develop uniform MCS protocols in the preoperative, intraoperative, and postoperative courses.
METHODS: An expert meeting was organized, and a questionnaire was sent out to all the invited participants before this expert meeting. An extensive literature research was conducted in order to enrich the results.
RESULTS: Topics that were addressed during the expert meeting were 1) inclusion and exclusion criteria, 2) targeting and methods of stimulation, 3) effects of MCS, and 4) results from the questionnaire.
CONCLUSIONS: Substantial commonalities but also important methodologic divergencies emerged from the discussion of MCS experts from 7 European Centers. From this meeting and questionnaire, all participants concluded that there is a need for more homogenous standardized protocols for MCS regarding patient selection, implantation procedure, stimulation parameters, and follow-up-course.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Expert meeting; Motor cortex stimulation; Neuropathic pain; Neurosurgery; Questionnaire

Mesh:

Year:  2017        PMID: 28882715     DOI: 10.1016/j.wneu.2017.08.168

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Brain stimulation patterns emulating endogenous thalamocortical input to parvalbumin-expressing interneurons reduce nociception in mice.

Authors:  Yeowool Huh; Dahee Jung; Taeyoon Seo; Sukkyu Sun; Su Hyun Kim; Hyewhon Rhim; Sooyoung Chung; Chong-Hyun Kim; Youngwoo Kwon; Marom Bikson; Yong-An Chung; Jeansok J Kim; Jeiwon Cho
Journal:  Brain Stimul       Date:  2018-05-18       Impact factor: 8.955

2.  New Developments in Non-invasive Brain Stimulation in Chronic Pain.

Authors:  Timothy J Meeker; Rithvic Jupudi; Frederik A Lenz; Joel D Greenspan
Journal:  Curr Phys Med Rehabil Rep       Date:  2020-05-11

Review 3.  Burst Motor Cortex Stimulation Evokes Sustained Suppression of Thalamic Stroke Pain: A Narrative Review and Single-Case Overview.

Authors:  Martin Nüssel; Melanie Hamperl; Anna Maslarova; Shafqat R Chaudhry; Julia Köhn; Andreas Stadlbauer; Michael Buchfelder; Thomas Kinfe
Journal:  Pain Ther       Date:  2020-12-16

4.  Motor cortex stimulation in chronic neuropathic orofacial pain syndromes: a systematic review and meta-analysis.

Authors:  Dylan Henssen; Erkan Kurt; Anne-Marie Van Cappellen van Walsum; Tamas Kozicz; Robert van Dongen; Ronald Bartels
Journal:  Sci Rep       Date:  2020-04-28       Impact factor: 4.379

Review 5.  Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials.

Authors:  Raffaele Ornello; Valeria Caponnetto; Susanna Ratti; Giulia D'Aurizio; Chiara Rosignoli; Francesca Pistoia; Michele Ferrara; Simona Sacco; Aurora D'Atri
Journal:  J Headache Pain       Date:  2021-11-27       Impact factor: 7.277

6.  Long-term effect of motor cortex stimulation in patients suffering from chronic neuropathic pain: An observational study.

Authors:  Dylan J H A Henssen; Erkan Kurt; Anne-Marie van Cappellen van Walsum; Inge Arnts; Jonne Doorduin; Tamas Kozicz; Robert van Dongen; Ronald H M A Bartels
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.